Related Experiment Video
Updated: Jul 11, 2026

08:52
Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
[Cutaneous side effects of antiangiogenic agents]
1Service de dermatologie, Institut Gustave Roussy, 39, rue Camille-Desmoulins, 94800 Villejuif. caroline.robert@igr.fr
Bulletin Du Cancer
|September 13, 2007
Summary
Antiangiogenic agents cause unique skin side effects. Understanding these cutaneous manifestations and their link to treatment response is crucial for better patient care.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Antiangiogenic agents are increasingly used in cancer therapy.
- These therapies can cause a range of cutaneous side effects.
- The spectrum of these skin symptoms is novel and requires characterization.
Purpose of the Study:
- To explore the correlation between molecular targets of antiangiogenic agents and their associated skin manifestations.
- To highlight the need for systematic reporting of side effects from targeted therapies.
- To improve understanding of skin pathophysiology in response to these treatments.
Main Methods:
- Review of existing literature on antiangiogenic agents and their side effects.
- Analysis of proposed correlations between drug targets and observed skin symptoms.
- Emphasis on the need for prospective studies.
Main Results:
- Antiangiogenic agents present a unique spectrum of cutaneous side effects.
- A potential correlation between molecular targets and specific skin manifestations is suggested.
- Further research is needed to confirm these associations.
Conclusions:
- Systematic characterization of skin side effects is critical for targeted therapies.
- Understanding these side effects can improve knowledge of skin pathophysiology.
- This knowledge will facilitate more effective symptomatic treatment for patients.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
